Ferroptosis and Hydrogen Sulfide in Cardiovascular Disease

被引:6
|
作者
Wu, Ze-Fan [1 ]
Yan, Bin-Jie [1 ]
Luo, Wen [1 ]
Gui, Dan-Dan [1 ]
Ren, Zhong [1 ]
Ma, Yun [1 ]
Jiang, Zhi-Sheng [1 ]
机构
[1] Univ South China, Inst Cardiovasc Dis, Key Lab Arteriosclerol Hunan Prov, Int Joint Lab Arteriosclerot Dis Res Hunan Prov, Hengyang 421001, Peoples R China
基金
中国国家自然科学基金;
关键词
Hydrogen sulfide; cardiovascular disease; ferroptosis; oxidative stress; signaling molecular; mechanism; ISCHEMIA-REPERFUSION INJURY; LIPID-PEROXIDATION; CELL-DEATH; ENDOTHELIAL DYSFUNCTION; MYOCARDIAL INJURY; OXIDATIVE STRESS; PROTECTS; ACTIVATION; IRON; PATHWAY;
D O I
10.2174/0929867329666220630144648
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ferroptosis is an iron-dependent cell death, characterized by the accumulation of lipid-reactive oxygen species; various regulatory mechanisms influence the course of ferroptosis. The rapid increase in cardiovascular diseases (CVDs) is an extremely urgent problem. CVDs are characterized by the progressive deterioration of the heart and blood vessels, eventually leading to circulatory system disorder. Accumulating evidence, however, has highlighted crucial roles of ferroptosis in CVDs. Hydrogen sulfide plays a significant part in anti-oxidative stress, which may participate in the general mechanism of ferroptosis and regulate it by some signaling molecules. This review has primarily summarized the effects of hydrogen sulfide on ferroptosis and cardiovascular disease, especially the antioxidative stress, and would provide a more effective direction for the clinical study of CVDs.
引用
收藏
页码:1848 / 1859
页数:12
相关论文
共 50 条
  • [1] Novel hydrogen sulfide therapeutics for cardiovascular disease
    Lefer, David J.
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2015, 47 : S9 - S9
  • [2] The Drug Developments of Hydrogen Sulfide on Cardiovascular Disease
    Wen, Ya-Dan
    Wang, Hong
    Zhu, Yi-Zhun
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
  • [3] The Emerging Roles of Hydrogen Sulfide in Ferroptosis
    Zhu, Yi-Wen
    Liu, Zi-Tao
    Tang, Ao-Qi
    Liang, Xiao-Yi
    Wang, Yan
    Liu, Ya-Fang
    Jin, Yu-Qing
    Gao, Wei
    Yuan, Hang
    Wang, Da-Yong
    Ji, Xin-Ying
    Wu, Dong-Dong
    ANTIOXIDANTS & REDOX SIGNALING, 2024, 41 (16-18) : 1150 - 1172
  • [4] Evolution of Hydrogen Sulfide Therapeutics to Treat Cardiovascular Disease
    Li, Zhen
    Polhemus, David J.
    Lefer, David J.
    CIRCULATION RESEARCH, 2018, 123 (05) : 590 - 600
  • [5] Ferroptosis in cardiovascular disease
    Liu, Guoqing
    Xie, Xiaoyong
    Liao, Wang
    Chen, Siyuan
    Zhong, Rumao
    Qin, Jiahui
    He, Peichun
    Xie, Jian
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 170
  • [6] Development of Hydrogen Sulfide-Based Therapeutics for Cardiovascular Disease
    Benjamin L. Predmore
    David J. Lefer
    Journal of Cardiovascular Translational Research, 2010, 3 : 487 - 498
  • [7] Development of Hydrogen Sulfide-Based Therapeutics for Cardiovascular Disease
    Predmore, Benjamin L.
    Lefer, David J.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2010, 3 (05) : 487 - 498
  • [8] Harnessing the Benefits of Endogenous Hydrogen Sulfide to Reduce Cardiovascular Disease
    Casin, Kevin M.
    Calvert, John W.
    ANTIOXIDANTS, 2021, 10 (03) : 1 - 20
  • [9] CARDIOVASCULAR ACTIONS OF HYDROGEN SULFIDE
    Lefer, David
    FREE RADICAL BIOLOGY AND MEDICINE, 2008, 45 : S9 - S9
  • [10] The role of hydrogen sulfide regulation of ferroptosis in different diseases
    Lian, Jingwen
    Chen, Yuhang
    Zhang, Yanting
    Guo, Shiyun
    Wang, Honggang
    APOPTOSIS, 2024, 29 (9-10) : 1377 - 1392